Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2024 Results Conference ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

When prostate cancer metastasizes, spreads outside of the prostate itself, it typically affects the structures in its immediate vicinity. Structures near the prostate likely to be involved include ...

covering a variety of urologic issues such as prostate cancer, male contraception ... reliable and highly accurate ablation.

First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...

Northwell Staten Island University Hospital has announced the addition of the Focal One High-Intensity Focused Ultrasound ...

Aquablation therapy, also called waterjet hydrodissection or ablation, is a minimally invasive procedure that uses an unheated jet of saline water to remove enlarged prostate tissue without ...

Pembrolizumab and stereotactic radiotherapy combined in subjects with advanced HCC: A phase II study (PEMRAD). This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium.

Development of a methylation-based, tissue-agnostic test for the detection of molecular residual disease by circulating tumor DNA. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal ...

AA = androgen ablation; D90 = percent of the prescribed dose that ≥90% of the prostate received; EBRT = external beam radiotherapy; PSA = prostate-specific antigen; V100 = percent volume ...

Debate – Management of Localized Radiorecurrent Prostate Cancer: Focal Ablation SUO 2024: Are We Missing Aggressive Cancer with PSA Screening Alone? Biochemical Recurrence After Radical Prostatectomy: ...